Healthcare AI models are becoming cheaper and more accessible. The durable venture moats are forming around workflow ownership, proprietary learning data, evidence, regulation, distribution, measurable economics, and platform expansion.
When nearly every appealed skilled-nursing denial is reversed, the lesson for healthcare AI is clear: authorization systems must be judged by completed care, not processing speed.
Healthcare AI is getting better at finding signals. The harder test is whether those signals turn into accountable action, completed care, and measured outcomes.
The next serious test for healthcare AI is not whether it can notice something humans might miss. It is whether the health system can turn that notice into completed care.
Harvard’s COMPASS model uses tumor gene activity to map cancer immunotherapy response, translating thousands of gene-expression signals into interpretable immune concepts.
A verification intelligence guide for reading healthcare AI claims with more discipline — and for separating real signal from narrative momentum.
A new Nature paper on autonomous medical AI agents points beyond chatbots and prediction models. The real test is whether AI can safely help healthcare move from signal to accountable…
England’s national AI chest X-ray rollout is a useful test of healthcare AI’s real promise: not just detecting a signal, but moving patients faster from scan to diagnosis, follow-up, and…
Healthcare AI has enough pilots, alerts, and dashboards. The harder question is whether any of them close the loop from signal to ownership, action, completed care, and measured result.
A drug whose target and molecule were both conceived by AI just improved lung function in a randomized Nature Medicine trial. Inside AI drug discovery’s 2026 clinical verdict, from Insilico’s…
Zach RobertsSign up for personalized wellness coaching and the Daily Discovery Newsletter.